Abstract

AimPatient‐reported outcome (PRO) measures (PROMs) are standard measures in the assessment of colorectal cancer (CRC) treatment, but the range and complexity of available PROMs may be hindering the synthesis of evidence. This systematic review aimed to: (i) summarize PROMs in studies of CRC surgery and (ii) categorize PRO content to inform the future development of an agreed minimum ‘core’ outcome set to be measured in all trials.MethodAll PROMs were identified from a systematic review of prospective CRC surgical studies. The type and frequency of PROMs in each study were summarized, and the number of items documented. All items were extracted and independently categorized by content by two researchers into ‘health domains’, and discrepancies were discussed with a patient and expert. Domain popularity and the distribution of items were summarized.ResultsFifty‐eight different PROMs were identified from the 104 included studies. There were 23 generic, four cancer‐specific, 11 disease‐specific and 16 symptom‐specific questionnaires, and three ad hoc measures. The most frequently used PROM was the EORTC QLQ‐C30 (50 studies), and most PROMs (n = 40, 69%) were used in only one study. Detailed examination of the 50 available measures identified 917 items, which were categorized into 51 domains. The domains comprising the most items were ‘anxiety’ (n = 85, 9.2%), ‘fatigue’ (n = 67, 7.3%) and ‘physical function’ (n = 63, 6.9%). No domains were included in all PROMs.ConclusionThere is major heterogeneity of PRO measurement and a wide variation in content assessed in the PROMs available for CRC. A core outcome set will improve PRO outcome measurement and reporting in CRC trials.

Highlights

  • The measurement of patient-reported outcomes (PROs) has become standard in the assessment of colorectal cancer (CRC) treatments, and their use is recommended by a2015 The Authors

  • Fifty-eight different patientreported outcome measures (PROMs) were identified from the 104 included studies

  • No domains were included in all PROMs

Read more

Summary

Introduction

The measurement of patient-reported outcomes (PROs) has become standard in the assessment of colorectal cancer (CRC) treatments, and their use is recommended by a2015 The Authors. Many patientreported outcome measures (PROMs) have been developed for a variety of purposes [2]. Each of these PROMs typically consists of a number of questions (items), which are often grouped together to represent similar concepts (scales). Two questions regarding activities of daily living and leisure activities in the EORTC QLQ-C30 measure are grouped into a single ‘role function’ scale. There are a multitude of ways to measure PROs to evaluate treatment for CRC, and this creates problems that may influence the conduct and clinical impact of trials

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call